financetom
Business
financetom
/
Business
/
Vita Coco Company Insider Sold Shares Worth $1,710,295, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vita Coco Company Insider Sold Shares Worth $1,710,295, According to a Recent SEC Filing
Oct 7, 2025 2:37 PM

05:02 PM EDT, 10/07/2025 (MT Newswires) -- Martin Roper, Director, Chief Executive Officer, on October 03, 2025, sold 40,000 shares in Vita Coco Company ( COCO ) for $1,710,295. Following the Form 4 filing with the SEC, Roper has control over a total of 573,628 common shares of the company, with 288,897 shares held directly and 284,731 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1482981/000120651325000023/xslF345X05/edgardoc.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TJ Maxx parent raises annual profit forecast
TJ Maxx parent raises annual profit forecast
Aug 21, 2024
Aug 21 (Reuters) - Off-price retailer TJX Cos ( TJX ) raised annual profit forecast on Wednesday, banking on gains from easing costs and steady demand for its low-price apparel and accessories. The company expects annual earnings per share of $4.09 to $4.13, above its prior forecast of $4.03 to $4.09. ...
BRIEF-Enterprise To Acquire Piñon Midstream For $950 Million
BRIEF-Enterprise To Acquire Piñon Midstream For $950 Million
Aug 21, 2024
Aug 21 (Reuters) - Enterprise Products Partners LP ( EPD ) : * ENTERPRISE TO ACQUIRE PIÑON MIDSTREAM * ENTERPRISE PRODUCTS PARTNERS LP ( EPD ) - TO ACQUIRE PIÑON MIDSTREAM FOR $950 MILLION * ENTERPRISE PRODUCTS PARTNERS LP ( EPD ) - TRANSACTION FUNDED USING CASH AND BORROWINGS * ENTERPRISE PRODUCTS PARTNERS ( EPD ): DEAL TO GENERATE DISTRIBUTABLE...
Bristol-Myers Squibb Says US FDA Accepts Supplemental BLA for Unresectable Hepatocellular Carcinoma Treatment
Bristol-Myers Squibb Says US FDA Accepts Supplemental BLA for Unresectable Hepatocellular Carcinoma Treatment
Aug 21, 2024
07:33 AM EDT, 08/21/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Wednesday that the US Food and Drug Administration has accepted the company's supplemental Biologics License Application for Opdivo plus Yervoy to treat adult patients with unresectable hepatocellular carcinoma. The FDA's acceptance was based on the company's late-stage trial, which showed a statistically significant and clinically meaningful improvement...
Target Q2 Earnings: Revenue And Profit Beat, Digital Sales Boost, Annual Profit Outlook Hiked
Target Q2 Earnings: Revenue And Profit Beat, Digital Sales Boost, Annual Profit Outlook Hiked
Aug 21, 2024
Target Corporation ( TGT ) shares soared as the retailer’s stellar second-quarter results outperformed earnings and sales expectations and prompted an optimistic boost to its full-year profit outlook. Quarterly adjusted earnings per share totaled $2.57 (+40%), beating the street view of $2.20. Target ( TGT ) reported sales of $25.45 billion (+2.7%), exceeding the analyst consensus of $25.229 billion. “Our...
Copyright 2023-2026 - www.financetom.com All Rights Reserved